ArticleAnalytical and bioanalytical chemistry2026
A valve-assisted 4-in-1 polarity-partitioned LC-QTOF-MS workflow reveals amino acid dysregulation in human chlorfenapyr poisoning.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Untargeted metabolomics of clinical toxicology samples is often constrained by limited sample volume, incomplete metabolome coverage, and technical variability introduced by multiple LC-MS injections. Here, we applied and evaluated a valve-assisted 4-in-1 polarity-partitioned LC-QTOF-MS workflow for single-injection plasma metabolomic profiling. The term "4-in-1" refers to four complementary LC-ionization data channels acquired from a single injection: HILIC-ESI(+), HILIC-ESI(-), C8-ESI(+), and C8-ESI(-). The workflow combines valve-controlled collection and transfer of weakly retained HILIC effluent with sequential HILIC and C8 analyses and dual-polarity MS acquisition. Quality-control analyses demonstrated stable retention behavior and reproducible feature detection, and the single-injection design reduced the need for multiple separate LC-MS injections. As a clinical toxicology application, the workflow was applied to plasma samples from patients with chlorfenapyr poisoning and healthy controls, with poisoned patients further stratified according to plasma tralopyril concentration. PCA and OPLS-DA were used as exploratory tools to visualize global metabolic differences. Differential LC-MS features were screened using multivariate and univariate statistical criteria, followed by metabolite annotation and pathway enrichment analysis based on annotated differential metabolites. Prominent perturbations were observed in amino acid metabolism, the urea cycle, and energy-related pathways. Several annotated amino acids, including glutamine, asparagine, alanine, and threonine, differed among the exposure groups. These exploratory findings support the feasibility of the workflow for limited-volume clinical plasma metabolomics and identify candidate metabolic alterations consistent with mitochondrial metabolic stress in chlorfenapyr poisoning.
Indexed as
Identifiers
42681074What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.